COOPDECH ENDOBRONCHIAL BLOCKER TUBE, MODELS BBT-A30XXX, BBT-B30XXX

K071694 · Daiken Medical Co, Ltd. · CBI · Mar 20, 2008 · Anesthesiology

Device Facts

Record IDK071694
Device NameCOOPDECH ENDOBRONCHIAL BLOCKER TUBE, MODELS BBT-A30XXX, BBT-B30XXX
ApplicantDaiken Medical Co, Ltd.
Product CodeCBI · Anesthesiology
Decision DateMar 20, 2008
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 868.5740
Device ClassClass 2
AttributesTherapeutic

Intended Use

The COOPDECH Endobronchial Blocker Tube is used to isolate the left or right lung of a patient for surgery, one lung ventilation or one lung anesthesia.

Device Story

Coopdech Endobronchial Blocker Tube consists of bronchial blocker tube and joint connector; designed for insertion through endotracheal catheter. Distal cuff inflated to block targeted bronchus; enables differential ventilation by isolating right or left lung. Used in hospital OR/ICU settings by clinicians. Device facilitates one-lung ventilation/anesthesia during surgery; benefits patient by allowing lung isolation. Performance verified via bench testing including bond strength, deflection angles, cuff pressure/dimension, balloon burst, and biocompatibility.

Clinical Evidence

Bench testing only. Tests included bond strength analysis, deflection angle analysis, cuff pressure/dimension testing, balloon burst testing, balloon cuff inflation retention, joint connector dimension/port evaluation, endotoxin testing, and biocompatibility testing.

Technological Characteristics

Tracheal/bronchial differential ventilation tube. Features bronchial blocker tube, joint connector, and distal inflatable cuff. Materials evaluated for biocompatibility. Mechanical design includes deflection capabilities. Sterilization method not specified.

Indications for Use

Indicated for patients requiring one lung isolation for surgery, one lung ventilation, or one lung anesthesia in hospital OR or ICU settings.

Regulatory Classification

Identification

A tracheal/bronchial differential ventilation tube is a device used to isolate the left or the right lung of a patient for anesthesia or pulmonary function testing.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the text "K071694" in a bold, handwritten-like font. Below this, the word "CONFIDENTIAL." is printed in a smaller, more formal font. The last line of text reads "DAIKEN MEDICAL CO., LTD" also in a formal font. The text appears to be part of a document or label. # 510 (k) SUMMARY #### Submitted By: Masahiko Nishimoto Director, Product Quality Center Daiken Medical Co., Ltd. 2-6-2 Ayumino, Izumi-city Osaka, Japan 594-1157 MAR 2 0 2008 #### Device: Trade Name: Coopdech Endobronchial Blocker Tube Tracheal/bronchial differential ventilation tube (w/wo connector) Common Name: Classification Name: Tube, Tracheal/bronchial, differential ventilation (w/wo connector) ## Predicate Device or Legally Marketed Devices: Cook "7.0 Fr. Endobronchial Blocker" (k021920) Cook "Tip Deflecting Endobronchial Blocker" (k013865) ## Device Description: The "Coopdech Endobronchial Blocker Tube" consists of a bronchial blocker tube; advanced through an endotracheal catheter, and a joint connecting the bronchial blocker tube to the endotracheal catheter. A cuff, incorporated at the distal tip of the tube, is inflated to block the targeted bronchus. The "Coopdech Endobronchial Blocker Tube" is intended for use to differentially intubate a patient's bronchus in order to isolate the right or left lung for procedures which require one-lung ventilation. #### Indications for Use: The COOPDECH Endobronchial Blocker Tube is used to isolate the left or right lung of a patient for surgery, one lung ventilation or one lung anesthesia. Patient Population: Patients requiring one lung isolation. Environment of Use: Hospitals-OR and ICU. #### Substantial Equivalence: The "Coopdech Endobronchial Blocker Tube" has the same intended use as the Cook "7.0 Fr. Endobronchial Blocker" (k021920) and the Cook "Tip Deflecting Endobronchial Blocker" (k013865). The "Coopdech Endobronchial Blocker Tube" has similar materials and design features as the Cook "7.0 Fr. Endobronchial Blocker" (k021920). Testing elements to verify the design of the Coopdech Endobronchial Blocker Tube are the Cook "Tip Deflecting Endobronchial Blocker" (k013865) indicating the same design features between the two products. The gas barrier property of the "Coopdech Endobronchial Blocker Tube" is at least equal to the Cook "7.0 Fr. Endobronchial Blocker" (k021920). {1}------------------------------------------------ Since the "Coopdech Endobronchial Blocker Tube" contains equivalent specifications, features and performance characteristics compared to both the Cook "7.0 Fr. Endobronchial Blocker" (k021920) and the Cook "Tip Deflecting Endobronchial Blocker" (k013865), DAIKEN ascertained that the "Coopdech Endobronchial Blocker Tube" is substantially equivalent to the above two (2) referenced devices. #### Test Data: . The Coopdech Endobronchial Blocker Tube was subjected to the following tests to assure reliable design and performance under the specified testing parameters. These tests included: - Analysis of Bond Strength - . Analysis of Deflection Angles - Analysis of Cuff Pressure and Dimension at Various Inflation Volumes . - . Balloon Burst Testing - Analysis of Balloon Cuff Inflation Retension (internal specification) • - . Evaluation of Balloon to Shaft Bond - t The dimension and the ports of the joint connector - Endotoxin tests . - Biocompatibility tests The results of these tests provide reasonable assurance that the device has been designed and tested to assure conformance to the requirements for use as a Bronchial Differential Ventilation Tube. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three stripes forming its wing. The eagle is positioned to the right of a circular border containing the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA". The text is arranged around the circle's perimeter. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 # MAR 2 0 2008 Daiken Medical Company, Limited C/O Fumiaki Kanai, Ph.D. President and Chief Executive Officer MIC International 4-2-1 Yushima, Bunkyou-ku Tokyo 113-0034 JAPAN Re: K071694 Trade/Device Name: Coopdech Endobronchial Blocker Tube Regulation Number: 21 CFR 868.5740 Regulation Name: Tracheal/Bronchial Differential Ventilation Tube Regulatory Class: II Product Code: CBI Dated: February 19, 2008 Received: February 21, 2008 Dear Dr. Kanai: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ Page 2 - Dr. Kanai Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely vours. Sutte y. Michaioms Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ## Indications for Use 510(k) Number (If known): 071694 Coopdech Endobronchial Blocker Tube Device Name: Indications for Use: The COOPDECH Endobronchial Blocker Tube is used to isolate the left or right lung of a patient for surgery, one lung ventilation or one lung anesthesia. Patient Population: Patients requiring one lung isolation. Environment of Use: Hospitals-OR and ICU. Prescription Use (Per 21 CFR 801 Subpart D) AND/OR Over-the Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Min 7hM (Division Sign-Off) (Division of Anesthesiology, General Hospital Infection Control, Dental Devices Page 1 of 1 510(k) Number: __ K07/694
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...